21 January 2019 2 Min Read
Philip Hampton to step down as Glaxo CEO ahead of split
In December, CEO Emma Walmsley noted a plan to split Glaxo into two units: one for prescription drugs and vaccines, the other for OTC products
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In